Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

EU Approves Baxter's Bid for Investor AB's Gambro-DJ


Monday, 22 Jul 2013 12:07pm EDT 

Dow Jones reported that Baxter International Inc. received conditional approval from the European Union (EU) to acquire the Swedish dialysis equipment maker Gambro AB from Investor AB. The European Commission stated though that the approval is subject to Baxter following through on plans to sell its continuous renal replacement therapy (CRRT) business, which serves patients suffering from acute kidney failure. 

Company Quote

283.3
2.3 +0.82%
11:29am EST